Publications

JAMA oncology

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

01-03-2022

Biopreservation and biobanking

Barriers and Facilitators for Implementing a National Guideline to Foster the Responsible Use of Residual Biospecimens and Data in Health Research.

01-02-2022

Breast (Edinburgh, Scotland)

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.

01-02-2022

Communications biology

Rare germline copy number variants (CNVs) and breast cancer risk.

18-01-2022

International journal of epidemiology

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.

06-01-2022

Breast cancer research : BCR

Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

04-01-2022

Genome medicine

Germline breast cancer susceptibility genes, tumor characteristics, and survival.

02-12-2021

Journal of pathology informatics

Browser-based Data Annotation, Active Learning, and Real-Time Distribution of Artificial Intelligence Models: From Tumor Tissue Microarrays to COVID-19 Radiology.

12-11-2021

British journal of cancer

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.

01-11-2021

Scientific reports

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

05-10-2021

Breast cancer research and treatment

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.

01-10-2021

The British journal of radiology

Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas.

01-10-2021

British journal of cancer

Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

01-10-2021

Data in brief

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period.

01-10-2021

NPJ breast cancer

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3^VNTR polymorphisms and gene co-expression.

10-09-2021

Breast cancer research and treatment

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer.

01-09-2021

European journal of cancer (Oxford, England : 1990)

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.

01-09-2021

Genetics in medicine : official journal of the American College of Medical Genetics

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

01-09-2021

Breast cancer research : BCR

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

18-08-2021

Nature

Genetic insights into biological mechanisms governing human ovarian ageing.

01-08-2021

Breast cancer research and treatment

Letter to the editor regarding: 'Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis'.

01-08-2021

Journal of the National Cancer Institute

Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.

01-07-2021

American journal of human genetics

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

01-07-2021

Cancers

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

14-05-2021

Nature communications

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

14-05-2021

NPJ breast cancer

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.

12-05-2021

International journal of cancer

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.

01-05-2021

Journal of hematology & oncology

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

17-04-2021

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

01-04-2021

Journal of the National Cancer Institute

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

01-03-2021

Nature communications

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

17-02-2021

The New England journal of medicine

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

04-02-2021

British journal of cancer

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

01-02-2021

Cancer medicine

Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.

01-01-2021

BMC medicine

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.

17-11-2020

American journal of human genetics

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

05-11-2020

Key Publication

NPJ breast cancer

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.

03-11-2020

Nature reviews. Clinical oncology

Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

01-11-2020

Genetics in medicine : official journal of the American College of Medical Genetics

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort.

01-11-2020

Nature reviews. Clinical oncology

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

01-11-2020

Breast (Edinburgh, Scotland)

Corrigendum to "The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer" [Breast 52 (2020) 102-109].

01-10-2020

NPJ breast cancer

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

24-09-2020

International journal of epidemiology

A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.

01-08-2020

Breast (Edinburgh, Scotland)

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer.

01-08-2020

Journal of medical genetics

Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation.

01-08-2020

Nature communications

Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

03-07-2020

Genetic epidemiology

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

01-07-2020

Scientific reports

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

16-06-2020

Nature genetics

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

01-06-2020

Breast cancer research and treatment

Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

01-06-2020

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

Barriers and Facilitators for Implementing a National Guideline to Foster the Responsible Use of Residual Biospecimens and Data in Health Research.

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.

Rare germline copy number variants (CNVs) and breast cancer risk.

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.

Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

Germline breast cancer susceptibility genes, tumor characteristics, and survival.

Browser-based Data Annotation, Active Learning, and Real-Time Distribution of Artificial Intelligence Models: From Tumor Tissue Microarrays to COVID-19 Radiology.

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.

Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas.

Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period.

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3VNTR polymorphisms and gene co-expression.

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer.

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

Genetic insights into biological mechanisms governing human ovarian ageing.

Letter to the editor regarding: 'Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis'.

Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.

Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort.

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Corrigendum to "The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer" [Breast 52 (2020) 102-109].

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer.

Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation.

Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

This site uses cookies

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3^VNTR polymorphisms and gene co-expression.